Skip to content

Released Oct 27, 2021, after the close

10-Q filed Oct 28, 2021, 28 days after period end · 0001653477-21-000065

Q3 2021 · 10-Q
Revenue$376.80M+13.6% vs Q3 2020+5.1% vs Q2 2021
Net Income-$4.20MN/M vs Q3 2020N/M vs Q2 2021
EPS Diluted-$0.11N/M vs Q3 2020N/M vs Q2 2021
Gross Profit$141,800,000+1.6%
Operating Income$119,500,000−6.3%
Operating Cash Flowderived$100,100,000+11.2%
Free Cash Flowderived$74,600,000+1.5%
Margins · derived
Gross margin37.6%−4.5 pt vs Q3 2020
Operating margin31.7%−6.8 pt vs Q3 2020
Net margin-1.1%−22.2 pt vs Q3 2020

What the release said

The release

Same quarter

MetricQ3 2021Q3 2020Q3 2019Q3 2018
Revenue$376.80M$331.70M$359.90M$311.20M
Net Income-$4.20M$69.90M$59.90M$49.50M
EPS Diluted-$0.11$1.69$1.41$1.16

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR